Higher levels of testosterone are associated with an increased risk of type 2 diabetes in women but play a protective role against type 2 diabetes in men.
The researchers aimed to identify the association between serum AMH levels and preterm delivery in women with PCOS who underwent in vitro fertilization.
Women with polycystic ovary syndrome report low health-related quality of life beyond the reproductive years.
Metabolic syndrome is associated with poorer sleep in girls with polycystic ovary syndrome and obesity.
Researchers performed a systematic review and meta-analysis to summarize and update the evidence regarding the effects of lifestyle intervention, including diet, on cardiometabolic risk among overweight and obese women with PCOS.
The study authors theorized that the interplay between inflammation and cytokines may influence mood and behavioral disturbances, which could explain the overlap between PCOS and bipolar disorder.
Symptoms of PCOS typically manifest during the early pubertal years, though diagnosing this condition in adolescence remains a clinical challenge.
Findings show that anti-Müllerian hormone (AMH) is a strong predictor for menstrual disturbance due to PCOS and that the risk for menstrual disturbance was increased with the degree of elevation of AMH.
In a cohort of premenopausal women with PCOS, metformin treatment for 3 months was associated with reduced bone turnover.
Letrozole treatment may significantly improve live birth rate compared with artificial-cycle frozen embryo transfer in women with polycystic ovary syndrome.
